Portal de investigación
- Inicio
- Proyectos y Estudios
- A multicentre, intra-patient randomised controlled Phase III study to confirm the efficacy and safety of denovoSkin™, a bilayer engineered collagen-based skin graft composed of autologous fibroblasts and keratinocytes, for the treatment of patients with deep partial and full-thickness burns.
A multicentre, intra-patient randomised controlled Phase III study to confirm the efficacy and safety of denovoSkin™, a bilayer engineered collagen-based skin graft composed of autologous fibroblasts and keratinocytes, for the treatment of patients with deep partial and full-thickness burns.
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
CUTISS A.G
Cita
A multicentre, intra-patient randomised controlled Phase III study to confirm the efficacy and safety of denovoSkin™, a bilayer engineered collagen-based skin graft composed of autologous fibroblasts and keratinocytes, for the treatment of patients with deep partial and full-thickness burns. (dS-BA-PIII). CUTISS A.G. 2025IP:MARÍA DOLORES PÉREZ DEL CAZ.